Axis Biochemicals, Shield Diagnostics Ltd. deal

The companies finalized the terms of their proposed merger (see BioCentury Jan. 25). AXI shareholders will receive 1.25 SDG shares for each AXI share and will hold 43 percent of the merged company. ...